Publications by authors named "Michael Lay"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

37,844

Total Likes

846

Extended Reach

260,218

Social Features

78
E
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.

N Engl J Med· October 2018

Videos about Article: user user

2 1 45 75 10 111 2

View All Article and Social Media Activity
M
Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohort.
Harry Magunia, Simone Lederer, Raphael Verbuecheln, Bryant Joseph Gilot, Michael Koeppen, Michael Lay

Crit Care· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating modifications to participant information materials to improve recruitment into a large randomized trial.

Trials· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.

N Engl J Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.
Arman Jahangiri, Alan Nguyen, Ankush Chandra, Maxim K Sidorov, Garima Yagnik, Michael De Lay

Proc Natl Acad Sci U S A· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Vitamin D on Blood Pressure, Arterial Stiffness, and Cardiac Function in Older People After 1 Year: BEST-D (Biochemical Efficacy and Safety Trial of Vitamin D).
Joseph Tomson, Harold Hin, Jonathan Emberson, Rijo Kurien, Michael Lay

J Am Heart Assoc· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance.
Ruby Kuang, Arman Jahangiri, Smita Mascharak, Alan Nguyen, Ankush Chandra, Michael De Lay

JCI Insight· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND).
Theingi Aung, Richard Haynes, Jill Barton, Jolyon Cox, Aleksandra Murawska, Michael Lay

Trials· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of the optimum dose of vitamin D for disease prevention in older people: rationale, design and baseline characteristics of the BEST-D trial.
Robert Clarke, Connie Newman, Joseph Tomson, Harold Hin, Rijo Kurien, Michael Lay

Maturitas· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol.
Richard Haynes, Colin Baigent, Paul Harden, Martin Landray, Murat Akyol, Michael Lay

Transplant Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.
Arman Jahangiri, Michael De Lay, Liane M Miller, W Shawn Carbonell, Yu-Long Hu

Clin Cancer Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-induced tumor cell autophagy mediates resistance to anti-angiogenic therapy.
Yu-Long Hu, Arman Jahangiri, Michael De Lay, Manish K Aghi

Autophagy· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.
Jakub Godlewski, Michal O Nowicki, Agnieszka Bronisz, Gerard Nuovo, Jeff Palatini, Michael De Lay

Mol Cell· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia.
Amy J Johnson, David M Lucas, Natarajan Muthusamy, Lisa L Smith, Ryan B Edwards, Michael D De Lay

Blood· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis